J&J joins forces with Monash University to advance novel technology

Press/Media: Article/Feature


Janssen Pharmaceutica N.V, one of the Janssen Pharmaceutical Companies of Johnson & Johnson has announced that it has entered into a sponsored research agreement with the Monash Institute of Pharmaceutical Sciences (MIPS) at Monash University to advance the development of an inhaled version of oxytocin to help prevent and manage Post-Partum Hemorrhage (PPH).

Period22 Mar 2019

Media coverage


Media coverage


  • Oxytocin
  • PPH
  • Postpartum haemorrhage
  • Pharmaceutical